Works matching IS 03682811 AND DT 2022 AND VI 52 AND IP 10

Results: 23
    1
    2
    3
    4

    Medical management of older patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1082, doi. 10.1093/jjco/hyac135
    By:
    • Zenke, Yoshitaka;
    • Hakozaki, Taiki;
    • Nakahara, Yoshiro;
    • Horinouchi, Hidehito;
    • Ohe, Yuichiro;
    • (JCOG), the Lung Cancer Study Group of the Japan Clinical Oncology Group
    Publication type:
    Article
    5
    6

    Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1242, doi. 10.1093/jjco/hyac127
    By:
    • Kukimoto, Iwao;
    • Onuki, Mamiko;
    • Yamamoto, Kasumi;
    • Yahata, Hideaki;
    • Aoki, Yoichi;
    • Yokota, Harushige;
    • Konnai, Katsuyuki;
    • Nio, Ai;
    • Takehara, Kazuhiro;
    • Kamiura, Shoji;
    • Tsuda, Naotake;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Nakai, Hidekatsu;
    • Yoshida, Hiroyuki;
    • Motohara, Takeshi;
    • Yamazaki, Hiroyuki;
    • Nakamura, Keiichiro;
    • Okunomiya, Asuka;
    • Tasaka, Nobutaka
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20)

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1225, doi. 10.1093/jjco/hyac105
    By:
    • Tomizawa, Daisuke;
    • Tsujimoto, Shin-ichi;
    • Tanaka, Shiro;
    • Matsubayashi, Jun;
    • Aoki, Takahiro;
    • Iwamoto, Shotaro;
    • Hasegawa, Daisuke;
    • Nagai, Kozo;
    • Nakashima, Kentaro;
    • Kawaguchi, Koji;
    • Deguchi, Takao;
    • Kiyokawa, Nobutaka;
    • Ohki, Kentaro;
    • Hiramatsu, Hidefumi;
    • Shiba, Norio;
    • Terui, Kiminori;
    • Saito, Akiko Moriya;
    • Kato, Motohiro;
    • Taga, Takashi;
    • Koshinaga, Tsugumichi
    Publication type:
    Article
    16
    17
    18

    Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1208, doi. 10.1093/jjco/hyac099
    By:
    • Yoshino, Maki;
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Nishimura, Koichi;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Toki, Daisuke;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    19

    Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1124, doi. 10.1093/jjco/hyac098
    By:
    • Saji, Shigehira;
    • Ohsumi, Shozo;
    • Ito, Mitsuya;
    • Hayashi, Naoki;
    • Kobayashi, Kokoro;
    • Masuda, Norikazu;
    • Niikura, Naoki;
    • Yamashita, Toshinari;
    • Kiyama, Keiichiro;
    • Hasegawa, Ayumi;
    • Nakagawa, Shizuka;
    • Hattori, Masaya
    Publication type:
    Article
    20
    21
    22
    23